XLOC_015548 Mitigates Skeletal Muscle Atrophy via the Gadd45g/MEK/ERK Pathway and Redox Regulation
Frontiers in Bioscience-Landmark · 2025
DOI: 10.31083/fbl36233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Tiantian Qi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone & Joint Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technolog…. Hauptthemen laut MEDLINE: Muscular Atrophy, MAP Kinase Signaling System, Muscle, Skeletal, RNA, Long Noncoding. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Key Medical Discipline Construction Fund, Sanming Project of Medicine in Shenzhen.
Abstract (Originalsprache)
Background
Skeletal muscle atrophy is a common musculoskeletal disorder that significantly reduces patient quality of life. Long non-coding RNA (lncRNA) XLOC_015548 has been identified as a pivotal regulator of C2C12 myoblast proliferation and differentiation. However, its role in mitigating denervation-induced muscle atrophy and the underlying mechanisms remain unclear.
Methods
We employed lentiviral-mediated stable expression of XLOC_015548 in C2C12 myoblasts and skeletal muscle-specific XLOC_015548-edited mouse models to investigate the function of this lncRNA. Muscle atrophy models were established in vitro by glucocorticoid-induced atrophy with dexamethasone (DEX) and in vivo by sciatic nerve transection-induced denervation. The MEK inhibitor U0126 was used to assess the role of the growth arrest and DNA damage-inducible 45 gamma/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (Gadd45g/MEK/ERK) signaling pathway.
Results
Overexpression of XLOC_015548 significantly activated the MEK/ERK signaling pathway (p < 0.05) by downregulating Gadd45g expression (p < 0.05) and promoting its cytoplasmic localization, thereby enhancing cell proliferation and myotube formation. Furthermore, XLOC_015548 reduced the level of reactive oxygen species (ROS) (p < 0.01), stabilized the mitochondrial membrane potential, and alleviated DEX-induced oxidative stress. These protective effects were partially reversed by U0126, confirming the involvement of the MEK/ERK pathway. Skeletal muscle-specific overexpression of XLOC_015548 in vivo significantly reduced denervation-induced muscle atrophy (q < 0.05) and increased the muscle fiber cross-sectional area.
Conclusion
XLOC_015548 plays a critical role in promoting myogenic differentiation and protecting against muscle atrophy by regulating Gadd45g expression, activating the MEK/ERK signaling pathway, and reducing oxidative stress. These findings underscore the therapeutic potential of XLOC_015548 in skeletal muscle atrophy, and provide a foundation for lncRNA-based treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bone & Joint Surgery, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, 518036 Shenzhen, Guangdong, China.
- National & Local Joint Engineering Research Center of Orthopaedic Biomaterials, 518036 Shenzhen, Guangdong, China.
- Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research, 518036 Shenzhen, Guangdong, China.
- Department of Spine Surgery, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, 518035 Shenzhen, Guangdong, China.
- Department of Orthopedic Trauma, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, 518035 Shenzhen, Guangdong, China.
Förderung
- National Natural Science Foundation of China
- Shenzhen Key Medical Discipline Construction Fund
- Sanming Project of Medicine in Shenzhen
- Shenzhen Science and Technology Program
- Guangdong Basic and Applied Basic Research Foundation
- The Scientific Research Foundation of PEKING UNIVERSITY SHENZHEN HOSPITAL
Zitieren
APA
Qi, T., Qin, H., Yu, F., Zhou, Z., Chen, Y., Liu, P., Zeng, H., & Weng, J. (2025). XLOC_015548 Mitigates Skeletal Muscle Atrophy via the Gadd45g/MEK/ERK Pathway and Redox Regulation. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl36233
Vancouver
Qi T, Qin H, Yu F, Zhou Z, Chen Y, Liu P, et al. XLOC_015548 Mitigates Skeletal Muscle Atrophy via the Gadd45g/MEK/ERK Pathway and Redox Regulation. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl36233
BibTeX
@article{Qi2025,
author = {Qi, Tiantian and Qin, Haotian and Yu, Fei and Zhou, Zimeng and Chen, Yingqi and Liu, Peng and Zeng, Hui and Weng, Jian},
title = {XLOC_015548 Mitigates Skeletal Muscle Atrophy via the Gadd45g/MEK/ERK Pathway and Redox Regulation},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
doi = {10.31083/fbl36233}
}
EUVIMED